Pyzik, Michal http://orcid.org/0000-0003-2591-6202
Kozicky, Lisa K. http://orcid.org/0000-0001-5487-4748
Gandhi, Amit K. http://orcid.org/0000-0003-0654-1097
Blumberg, Richard S. http://orcid.org/0000-0002-9704-248X
Article History
Accepted: 29 November 2022
First Online: 1 February 2023
Competing interests
: R.S.B. had equity interests in Syntimmune Inc., a company developing therapeutic agents to target FcRn. Syntimmune Inc. was a wholly owned subsidiary of Alexion Pharmaceuticals Inc., which was acquired by AstraZeneca. M.P., L.K.K. and A.G. declare no competing interests.
Free to read: This content has been made available to all.